SCHEMBL10028209

SCHEMBL10028209

c1ccc2c(c1)c1oc3c(-c4ccc5c6ccccc6c6oc7cccc8c9ccccc9c9oc4c5c6-c9c78)ccc4c5ccccc5c5oc6cccc2c6c1-c5c34

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.43
CDC25A P30304 2/20 0.39
CDC25C P30307 2/20 0.39
CDC25B P30305 1/20 0.39
ARSA P15289 1/20 0.35
PGR P06401 1/20 0.35
CDC14B O60729 3/20 0.34
CDC14A Q9UNH5 3/20 0.34
MAOA P21397 2/20 0.33
AHR P35869 1/20 0.33
EGFR P00533 1/20 0.33
HPGD P15428 2/20 0.33
HSD17B10 Q99714 2/20 0.33
KDM4E B2RXH2 1/20 0.33
MEN1 O00255 1/20 0.33
CYP3A4 P08684 1/20 0.33
ALPI P09923 1/20 0.33
GAA P10253 1/20 0.33
MAPT P10636 1/20 0.33
PKM P14618 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10028238 0.87 ALDH1A1 (0.41) ALOX5CDC25ACDC25CCDC25BPGR
SCHEMBL10028208 0.84 CDC14B (0.36) ALOX5CDC25ACDC25CCDC25BARSA
SCHEMBL10028165 0.83 ARSA (0.43) ALOX5CDC25ACDC25CARSAHPGD
SCHEMBL10028210 0.82 ARSA (0.38) ALOX5CDC25ACDC25CARSAMAOA
SCHEMBL10028163 0.82 CDC14B (0.38) CDC25ACDC25CCDC25BARSACDC14B
SCHEMBL10028168 0.74 CYP1A2 (0.36) CDC25ACDC25CARSAPGRMAPT
SCHEMBL17431163 0.74 ALOX5 (0.50) ALOX5CDC25ACDC25CCDC25BPGR
SCHEMBL24004243 0.73 CA1 (0.41) ALOX5CDC25ACDC25CCDC25BCDC14B
SCHEMBL10028164 0.73 GPR84 (0.44) ALOX5CDC25ACDC25CARSAHPGD
SCHEMBL15164538 0.73 ALOX5 (0.58) ALOX5CDC25ACDC25CCDC25BMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2046915-B1 NEW MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2015-12-02 EP disclosed
US-8114531-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2012-02-14 US disclosed
US-8114531-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2012-02-14 US disclosed
US-20100013381-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2010-01-21 US disclosed
US-20100013381-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2010-01-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100013381-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES L1CAM, SOD1, SLC40A1 ALOX5 2515/4885CDC25A 3550/4885CDC25C 3939/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.